Clinical Trial Update: The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study [Phase 3]

View source ↗

Summary

Phase 3 pilot trial investigating long-acting mesalamine for post-infective irritable bowel syndrome; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• long-acting mesalamine (mesalamine)

Snippet

Sponsor: University of Utah | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-12-31